[ad_1]
Jeff Sidell, PhD, chief technology officer at Advarra, recently discussed the current challenges in clinical research technology in an interview with Applied Clinical Trials (ACT). He highlighted the need for integration to streamline processes and reduce administrative overhead caused by the overabundance of systems in the industry. Sidell emphasized the potential of AI and predictive analytics to automate repetitive tasks, improving efficiency and quality.
In the interview, Sidell stressed the importance of integration in addressing the technology overload in the industry. He acknowledged the complexities involved in choosing the right integration solution but expressed optimism about the possibility of achieving seamless integration across systems. Advarra, with its involvement in the entire clinical trial process from protocol submission to trial conduct, is positioned to be a key player in providing integration solutions.
Sidell’s insights shed light on the industry’s efforts to harness technology to enhance clinical research processes. By leveraging AI and predictive analytics, stakeholders can streamline operations, reduce administrative burden, and improve the overall quality of clinical trials. Advarra’s focus on integration and advancements in technology positions the company as a leading provider of solutions in the rapidly evolving clinical research technology landscape.
As the industry continues to progress, the integration of systems and adoption of AI technologies will play a crucial role in shaping the future of clinical research. By embracing these advancements, stakeholders can overcome current challenges and drive innovation in the field.
Source
Photo credit www.appliedclinicaltrialsonline.com
